SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 77.61+3.5%Nov 21 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (2772)6/8/2010 12:32:19 PM
From: Jibacoa1 Recommendation  Read Replies (1) of 3722
 
CRTX is also among the group that will be presenting on Friday at the Jefferies 2010 Global Life Sciences Conference at the Hyatt Hotel in N.Y.

The stock is still up a modest 4.73%, which isn't bad these days.<g>
Volume remains modes, but is > 1/3 its ADV.

bigcharts.marketwatch.com

As previously mentioned, CRTX has 4Qs of better revenues, but earnings have been lower.<g>

However, the earnings on the 1stQ were better than I though, albeit still lower than in 2009.

CRTX is trading below BV, it has negligible LTD, the insiders hold a good % of the stock and it has +CF.
The ACTAY is $10.50 which would be almost a double.<g>

As also mentioned, in the Wall Street Transcript Biotechnology & Pharmaceuticals Report, it mentions CRTX as a "sleeper stock that is immensely profitable".<g>

It seems that the R/R isn't bad at present levels.<g>

bigcharts.marketwatch.com

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext